⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BWAY News
Brainsway Ltd. American Depositary Shares
BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025
globenewswire.com
BWAY
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
globenewswire.com
BWAY
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
globenewswire.com
BWAY
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder
globenewswire.com
BWAY
BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025
globenewswire.com
BWAY
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
globenewswire.com
BWAY
Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay USA - English Israel - English
prnewswire.com
BWAY